SXTP director files initial Form 3 ownership report

60 Degrees Pharmaceuticals, Inc. director Francois Eric filed an initial Form 3, which is a statement of beneficial ownership for insiders.

Rhea-AI Filing Summary

60 Degrees Pharmaceuticals, Inc. director Francois Eric filed an initial Form 3, which is a statement of beneficial ownership for insiders. This filing does not list any stock purchases, sales, option exercises, or other transactions, and serves mainly to register his status as a reporting person.

Key Terms

Form 3, beneficial ownership, reporting person

3 terms

Form 3 regulatory

"filed an initial Form 3, which is a statement of beneficial ownership"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

beneficial ownership financial

"initial Form 3, which is a statement of beneficial ownership for insiders"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

reporting person regulatory

"register his status as a reporting person"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the SXTP Form 3 filed by Francois Eric show?

The Form 3 for 60 Degrees Pharmaceuticals director Francois Eric reports his status as an insider. It does not list any stock purchases, sales, or option exercises, and functions as an initial beneficial ownership statement required by SEC rules.

Are there any buy or sell transactions in the SXTP Form 3?

No, the SXTP Form 3 shows no buy, sell, or other share transactions. All transaction counters in the summary are zero, indicating the filing is purely an initial ownership report without recent trading activity disclosed for the director.

Does the SXTP Form 3 indicate option exercises or derivative activity?

No, the Form 3 shows zero derivative transactions and zero exercise-related shares. The derivativeSummary section is empty, meaning no options, warrants, or other derivative securities are reported as newly exercised or otherwise transacted in this particular filing.

What is the role of the reporting person in the SXTP Form 3?

The reporting person, Francois Eric, is identified as a director of 60 Degrees Pharmaceuticals, Inc. Being a director makes him a Section 16 insider, which triggers the requirement to file this initial Form 3 reporting his beneficial ownership position to the SEC.

Does the SXTP Form 3 include any Rule 10b5-1 trading plan details?

The provided Form 3 data does not include any references to Rule 10b5-1 trading plans. Footnotes are effectively empty, so there is no indication that any pre-arranged trading programs are associated with this specific insider ownership disclosure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/19/2026 - 06:14 PM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Francois Eric

(Last) (First) (Middle)

C/O 60 DEGREES PHARMACEUTICALS, INC.

1025 CONNECTICUT AVENUE NW SUITE 1000

(Street)

WASHINGTON DISTRICT OF COLUMBIA 20036

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
05/13/2026

3. Issuer Name and Ticker or Trading Symbol
60 DEGREES PHARMACEUTICALS, INC. [ SXTP ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Eric Francois	05/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)